Drug intelligence / Profile preview

Mecxin OD

Development stage
Unknown
Lead developer
Stevia Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Mecxin OD is an oral pharmaceutical product developed by Stevia Pharmaceuticals, featuring a once-daily (OD) tablet formulation of 1500 mcg methylcobalamin. Methylcobalamin is a biologically active coenzyme form of Vitamin B12 that plays a critical role in the one-carbon metabolism pathway and the maintenance of the nervous system. It is primarily indicated for the treatment of Vitamin B12 deficiency and associated neurological conditions, such as peripheral neuropathy. By acting as a cofactor for the enzyme methionine synthase, methylcobalamin facilitates the conversion of homocysteine to methionine, a process essential for DNA synthesis and the maintenance of the myelin sheath that protects nerve fibers.

Brand names
Mecxin ODMecxin OD Tablets
Other names
methylcobalaminmecobalaminVitamin B12
02

Targets

MTR (Methionine synthase)

Beyond the preview

Go deeper on Mecxin OD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mecxin OD.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call